CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
etafilcon - PVP (multi-focal)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02345720
NCT02345720N/ACompleted

Effects on Ocular Tissues of Vistakon® Investigational Multifocal Contact Lenses - Asian Population Study

Johnson & Johnson Vision Care, Inc.·interventional·Posted Jan 26, 2015·Updated Jun 19, 2018

In Brief

A clinical study evaluating etafilcon - PVP (multi-focal) for Visual Acuity. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the etafilcon - PVP (multi-focal)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 26, 2015
Enrollment StartDec 1, 2014
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.4 years ago

Interventions

etafilcon - PVP (multi-focal)device

The investigational contact lens must be worn at least six hours daily.